This Blog is also available as an RSS Feed

• China Re-opens Initial Public Offerings on Bourses - Editor, 29 June 2009

Following an almost ten month restriction on initial public offerings (IPO), on China's bourses, the Chinese government has given the go-ahead for Guilin Sanjin Pharmaceuticals to list on the Shenzhen exchange. Primarily the manufacturer of traditional Chinese medicines, Guilin Sanjin Pharmaceuticals anticipates raising $133 million (910.8 million yuan) through the sale of 46 million shares, starting Monday 29 June. With global IPOs being down 85 percent year to date compared with the same period last year, this easing of restrictions is not only good news for the company, it is also seen as good news for global investors who are facing a shrinking pool of investment opportunities.